Contact: info@peptomertherapeutics.com
Kantaraja Chindera
Founder
Peptomer Therapeutics
Peptomer Therapeutics Private Limited
Antimicrobial resistance (AMR) poses serious and escalating global health challenges. In response to this critical need, Peptomer Therapeutics aims to address this issue by creating a new class of highly effective antimicrobials.
They are working on developing new generation of oligomers and peptidomimetics as alternatives to antibiotics.